Taysha Gene Therapies

60 people · 0 jobs
‌

Taysha Gene Therapies is on a mission to eradicate severe and life-threatening monogenic CNS disease. With a singular focus on developing curative medicines, they hope to rapidly translate their treatments from bench to bedside.

Industries

Employees

51-200

Links


Org chart

Sean Nolan
Chief Executive Officer
Collapse
Kamran Alam
Chief Financial Officer
Tracy M. Porter
Chief People Officer
Sean Mcauliffe
Chief Business Officer
Fred Porter
Chief Technical Officer
Emily McGinnis
Chief Patient And External Affairs Officer
Rumana Haque-Ahmed
Chief Regulatory Officer
Eshetu Tesfaye
Ex. Director, Biostatistics
Melissa A. Ellis
Senior Executive Assistant to the Chairman & CEO

Board & advisors